Basic Rate
Basic Rate. Is, as of the Funding Date, the per annum- rate of interest (based on a year of 360 days) equal to the sum of (a) the U.S. Treasury note yield to maturity for a term equal to the Treasury Note Maturity as quoted in The Wall Street Journal on the day the Loan Supplement is prepared, plus (b) the Loan Margin.
Found in
ADAYTUM SOFTWARE INC contract
Basic Rate. Is, as to each Equipment Advance, the Prime Rate, as that rate shall change from time to time.
Found in
Exelixis contract
Basic Rate. Is, as of the Funding Date, the per annum rate of interest (based on a year of 360 days) equal to one and one half of one percentage points (1.50%) above the Prime Rate. 10
Found in
VIACELL INC contract
Basic Rate. Is, as of the Funding Date the per annum rate of interest (based on a year of 360 days) equal to the sum of (a) U.S. Treasury note yield to maturity for a term equal to thirty-six months as quoted in the Wall Street Journal on the Funding Date, plus (b) the Loan Margin.
Basic Rate. The per annum rate of interest (based on a year of 360 days) equal to the sum of (a) U.S. Treasury note yield to maturity for a term equal to the Treasury Note Maturity as reported in the Federal Reserve Statistical Release H.15-Selected Interest Rates under the heading U.S. Government Securities/Treasury Constant Maturities on the Funding Date, plus (b) the Loan Margin. (In the event Release H.15 is no longer published, Bank shall select a comparable publication to determine the U.S. Treasury...
View More
Found in
Intersect ENT, Inc. contract
Basic Rate. With respect to a Term Loan, the per annum rate of interest (based on a year of three hundred sixty (360) days) equal to the greater of (i) eight and ninety-four hundredths percent (8.94%) and (ii) the sum of (a) the thirty (30) day U.S. LIBOR rate reported in The Wall Street Journal on the last Business Day of the month that immediately precedes the month in which the interest will accrue, plus (b) six and ninety-four hundredths percent (6.94%)
All Definitions
Found in
Poseida Therapeutics, Inc. contract